Black Friday Get Elite for just $149.00 Claim Now

BioNTech price target lowered to $130 from $145 at Citi

By TheFly | March 11, 2026, 5:55 AM

Citi lowered the firm’s price target on BioNTech (BNTX) to $130 from $145 and keeps a Buy rating on the shares. The departures of the company’s co-founders is a surprise but the share selloff offers a good entry point, the analyst tells investors in a research note. Citi says BioNTech’s pipeline has multiple Phase 3 opportunities.

Claim 70% Off TipRanks Premium

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Mentioned In This Article

Latest News

Nov-12
Nov-12
Nov-03
Nov-03
Nov-03
Oct-26
Oct-26
Oct-25
Oct-23
Oct-22
Oct-20
Oct-19
Oct-13
Oct-13
Oct-13